Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses’ Health Study

[1]  R. Stern,et al.  Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study. , 2011, The Journal of investigative dermatology.

[2]  S. Gruber,et al.  Nonsteroidal Anti-Inflammatory Drugs and Risk of Melanoma , 2011, Journal of skin cancer.

[3]  B. Elewski,et al.  Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial , 2010, Journal of the National Cancer Institute.

[4]  Rajiv Kumar,et al.  Genetics of pigmentation in skin cancer--a review. , 2010, Mutation research.

[5]  M. Chren,et al.  Association between nonsteroidal anti-inflammatory drug use and cutaneous squamous cell carcinoma. , 2010, Archives of dermatology.

[6]  Donna Spiegelman,et al.  Aspirin intake and survival after breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  C. McCulloch,et al.  Basal Cell Carcinoma Chemoprevention with Nonsteroidal Anti-inflammatory Drugs in Genetically Predisposed PTCH1+/− Humans and Mice , 2010, Cancer Prevention Research.

[8]  R. Herings,et al.  Non-steroidal anti-inflammatory drugs and melanoma risk: large Dutch population-based case-control study. , 2009, The Journal of investigative dermatology.

[9]  K. Srivenugopal,et al.  Efficacy of acetaminophen in skin B16-F0 melanoma tumor-bearing C57BL/6 mice. , 2009, International journal of oncology.

[10]  G. Yount,et al.  Biochemical mechanism of acetaminophen (APAP) induced toxicity in melanoma cell lines. , 2009, Journal of pharmaceutical sciences.

[11]  Robin B Harris,et al.  Effect of non‐steroidal anti‐inflammatory drugs on non‐melanoma skin cancer incidence in the SKICAP‐AK trial , 2009, Pharmacoepidemiology and drug safety.

[12]  G. T. Bowden,et al.  UVB irradiation regulates Cox‐2 mRNA stability through AMPK and HuR in human keratinocytes , 2008, Molecular carcinogenesis.

[13]  E. White,et al.  A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence. , 2008, Journal of the National Cancer Institute.

[14]  S. Hankinson,et al.  Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer. , 2008, Cancer research.

[15]  U. Vogel,et al.  Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes. , 2007, Mutation research.

[16]  J. Manson,et al.  Long-term aspirin use and mortality in women. , 2007, Archives of internal medicine.

[17]  J. Fraumeni,et al.  Cancer epidemiology and prevention. , 2006 .

[18]  M. Karagas,et al.  Effect of NSAIDs on the recurrence of nonmelanoma skin cancer , 2006, International journal of cancer.

[19]  D. Whiteman,et al.  Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin. , 2005, Journal of the American Academy of Dermatology.

[20]  J. Meyerhardt,et al.  Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. , 2005, JAMA.

[21]  D. Federman,et al.  Use of Cyclooxygenase Inhibitors and Risk of Melanoma in High‐Risk Patients , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[22]  Graham A Colditz,et al.  Risk factors and individual probabilities of melanoma for whites. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  G. Colditz,et al.  A prospective study of aspirin use and the risk of pancreatic cancer in women. , 2004, Journal of the National Cancer Institute.

[24]  D Feskanich,et al.  Dietary intakes of vitamins A, C, and E and risk of melanoma in two cohorts of women , 2003, British Journal of Cancer.

[25]  W. Leslie,et al.  Selective Cyclooxygenase‐2 Inhibition: A Target in Cancer Prevention and Treatment , 2003, Pharmacotherapy.

[26]  Kathleen M. Fairfield,et al.  Aspirin, other NSAIDs, and ovarian cancer risk (United States) , 2002, Cancer Causes & Control.

[27]  K. Namboodiri,et al.  Inverse association of non-steroidal anti-inflammatory drugs and malignant melanoma among women. , 2001, Oncology reports.

[28]  Weiya Ma,et al.  Inhibition of Ultraviolet B-induced Activator Protein-1 (AP-1) Activity by Aspirin in AP-1-Luciferase Transgenic Mice* , 1997, The Journal of Biological Chemistry.

[29]  M. Kerin.  Cancer principles and practice of oncology , 1997 .

[30]  G A Colditz,et al.  Reproducibility and validity of a self-administered physical activity questionnaire. , 1994, International journal of epidemiology.

[31]  G A Colditz,et al.  Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. , 1992, American journal of epidemiology.

[32]  W. Willett,et al.  Risk factors for basal cell carcinoma in a prospective cohort of women. , 1990, Annals of epidemiology.

[33]  J. Scotto,et al.  Biologically effective ultraviolet radiation: surface measurements in the United States, 1974 to 1985. , 1988, Science.

[34]  W. Willett,et al.  Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. , 1986, American journal of epidemiology.

[35]  W. Willett,et al.  Reproducibility and validity of a semiquantitative food frequency questionnaire. , 1985, American journal of epidemiology.

[36]  R. Hayes,et al.  Cancer Causes & Control , 2004, Cancer Causes & Control.

[37]  M. Demierre,et al.  Chemoprevention of melanoma: an unexplored strategy. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  C. Denkert,et al.  Expression of cyclooxygenase 2 in human malignant melanoma. , 2001, Cancer research.

[39]  S. Gruber,et al.  Sensitivity and specificity of self-examination for cutaneous malignant melanoma risk factors. , 1993, American Journal of Preventive Medicine.

[40]  J C Briggs,et al.  Cutaneous melanoma. , 1993, Journal of the American Academy of Dermatology.